Featured Article in Global Family Office Journal – A Proud Moment for Swiss Rockets

In the article titled “Investing in Health Programs for Society: The Role of Innovation and Impact Investing”, I discuss how Swiss Rockets and our subsidiaries—Rocketvax, Torqur, and Torpedo Pharmaceuticals—are addressing some of the most urgent medical challenges through next-generation therapies for infectious diseases, cancer, and autoimmune conditions.

The piece emphasizes:

• Our approach to impact investing in biotech.
• The strategic value of direct access to founders and scientists.
• The growing social and financial relevance of preventive healthcare.
• How family offices and private investors can contribute to meaningful change.

Click here to download the PDF copy of the article.